Diastolic heart failure in the community
Tóm tắt
Although it is now widely recognized that isolated diastolic dysfunction can lead to the classic signs and symptoms of congestive heart failure (CHF), this disease process is poorly understood and remains of great interest and concern to cardiovascular disease specialists, as well as to primary care physicians. Recent epidemiologic data have suggested that diastolic heart failure is predominantly a disease of the elderly, the fastest growing segment of our population. Diagnosis is often difficult in this subgroup of patients due to the presence of confounding comorbidities. However, early identification in community-based practices and timely intervention is important due to the significant disability and death that results from this progressive disease process. The poor prognosis of CHF patients with systolic dysfunction is shared by those with isolated diastolic heart failure and preserved systolic function. Further studies of the prevalence, clinical characteristics, and natural history of patients with diastolic dysfunction are needed. This review focuses on the emerging data regarding the prevalence and natural history of diastolic heart failure in the community.
Tài liệu tham khảo
Graves EG, Gillum BS: 1994 Summary: National Hospital Discharge Survey: advance data. National Center for Health Statistics 1996, 278:1–12.
O’Connell JB, Bristow MR: Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994, 13:S107-S112.
Gillum RF: Epidemiology of heart failure in the United States. Am Heart J 1993, 126:1042–1047.
Senni M, Tribouilloy CM, Rodeheffer RJ, et al.: Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998, 98:2282–2289. An important large community-based study inclusive of the elderly population and shows the high prevalence of diastolic heart failure among patients with a first diagnosis of CHF. The prognosis for patients with CHF and preserved ejection fraction is also reported.
Vasan RS, Larson MG, Benjamin EJ, et al.: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a populationbased cohort. J Am Coll Cardiol 1999, 33:1948–1955. Another community-based study of CHF patients with normal and reduced systolic function and long-term mortality outcomes. Confirms the high prevalence of diastolic heart failure in the community setting.
Setaro JF, Soufer R, Remetz MS, et al.: Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol 1992, 69:1212–1216.
European Study Group on Diastolic Heart Failure: How to diagnose diastolic heart failure. European Heart Journal 1998, 19:990–1003.
Lainchbury JG, Redfield MM: Doppler echocardiographicguided diagnosis and therapy of heart failure. Curr Cardiol Reports 1999, 1:55–66. This is a recent review on Doppler echocardiographic assessment of diastolic function, an important clinical tool to aid in the diagnosis of diastolic heart failure.
Cheng C-P, Noda T, Nozawa T, Little WC: Effect of heart failure on the mechanism of exercise-induced augmentation of mitral valve flow. Circ Res 1993, 72:795–806.
Kitzman DW, Higginbotham MB, Cobb FR, et al.: Exercise intolerance in patients with heart failure and preserved left ventricular systolic function - failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991, 17:1065–1072.
Brutsaert DL, Sys SU: Diastolic dysfunction in heart failure. J Card Failure 1997, 3:225–242.
McKee PA, Castelli WD, McNamara PM, et al.: The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971, 26:1441–1446.
Burt VL, Whelton P, Roccella EJ, et al.: Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 1995, 25:305–313.
Kannel WB, Belanger AJ: Epidemiology of heart failure. Am Heart J 1991, 121:951–957.
Vasan RS, Benjamin EJ, Levy D: Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995, 26:1565–1574.
Dougherty AH, Naccarelli GV, Gray EL, et al.: Congestive heart failure with normal systolic function. Am J Cardiol 1984, 54:778–782.
Soufer R, Wohlgelernter D, Vita NA, et al.: Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985, 55:1032–1036.
Cohn JN, Johnson G: Heart failure with normal ejection fraction - the V-HeFT study. Circulation 1990, 81(suppl III): III–48-III–53.
Thomas JT, Kelly RF, Thomas SJ, et al.: History, physical exam, ECG, and chest x-ray do not differentiate normal from decreased systolic function in patients with congestive heart failure [abstract]. Circulation 1999, 100(18):I-381.
The SAVE Investigators: Effect of captopril on mortality and morbidity in patients with ventricular dysfunction after myocardial infarction - Results of the Survival and Ventricular Enlargement trial. N Engl J Med 1992, 327:669–677.
The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991, 325:293–302.
McDonagh TA, Morrison CE, Lawrence A, et al.: Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997, 350(9081):829–833.
Redfield MM, Mahoney DW, Jacobsen SJ, Rodeheffer RJ: Isolated diastolic dysfunction in the community [abstract]. Circulation 1999, 100(18) (suppl):I-381.
Rich MW: Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997, 45:968–974.
Frohlich ED, Apstein C, Chobanian AV, et al.: The heart in hypertension. N Engl J Med 1992, 327(14):998–1008.
Cuocolo A, Sax FL, Brush JE, et al.: Left ventricular hypertrophy and impaired diastolic filling in essential hypertension - diastolic mechanisms for systolic dysfunction during exercise. Circulation 1990, 81:978–986.
Meissner I, Whisnant JP, Sheps SG, et al.: Detection and control of high blood pressure in the community: do we need a wake-up call? Hypertension 1999, 34:466–471. This population-based study raises the concern that at the community level, hypertension awareness and blood pressure control rates are suboptimal. This is important since hypertension is the most important risk factor in the development of CHF.
Levy D, Larson MG, Vasan RS, et al.: The progression from hypertension to congestive heart failure. JAMA 1996, 275(20):1557–1562.
Yamamoto K, Wilson DJ, Canzanello VJ, Redfield MM: Left ventricular diastolic dysfunction in patients with hypertension and preserved systolic function. Mayo Clin Proc 2000, 75:148–155.
Setaro JF, Zaret BL, Schulman DS, et al.: Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990, 66:981–986.
Aldigier JC, Huang H, Dalmay F, et al.: Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans. J Cardiovasc Pharmacol 1993, 21:289–295.
Warner JG, Metzger DC, Kitzman DW, Wesley DJ, Little WC: Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999, 33:1567–1572. This is an important study evaluating therapy for isolated diastolic dysfunction since currently only a few studies exist. This study showed that exercise tolerance in patients with diastolic dysfunction was improved and well-tolerated with angiotensin II blockade.
Topol EJ, Traill TA, Fortuin NJ: Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985, 312:277–283.
Shah AM, Spurgeon HA, Sollott SJ, et al.: 8-bromo-cGMP reduces the myofilament response to calcium in intact cardiac myocyte. Circ Res 1994, 74:970–978.
Yamamoto K, Burnett JC Jr., Redfield MM: Effect of the endogenous natriuretic peptide system on ventricular and coronary function in the failing canine heart. Am J Physiol 1997, 273:H2406-H2414.
Lainchbury JG, Burnett JC Jr., Redfield MM: Effect of the natriuretic peptides on load and myocardial function in normal and heart failure dogs. Am J Physiol 2000, in press.
Teramae CY, Hahn EL, Burnett JC Jr., et al.: Regulation of systolic and diastolic function by endogenous cGMP in experimental heart failure [abstract].J Am Coll Cardiol 2000, in press.
Clarkson PBM, Wheeldon NM, MacFadyen RJ, et al.: Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. Circulation 1996, 93:2037–2042.
Parmley WW: Do we practice geriatric cardiology [editorial]? J Am Coll Cardiol 1997, 29:217–218.